MATHLOUTHI AHMED

Dr. MATHLOUTHI AHMED


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2018 in Journal of Essential Oil Bearing Plants
Verified
Journal Article
Closed access
MAMATHLOUTHI AHMED
MATHLOUTHI AHMED
Mouna BELKESSAMMouna BELKESSAM
Mouna BELKESSAM
MSMouna Sdiri
Mouna Sdiri
MDMohamed Fethi Diouani
Mohamed Fethi Diouani
ASAbdelaziz Souli
Abdelaziz Souli
MBMossadok Ben-Attia
Mossadok Ben-Attia
Natural products are a very important source of bio-molecules for drug to treat infectious diseases. New antileishmanial agents are timely needed, due to leishmania toxicity, drug-resistant strains and high costs treatments. In this study, we report the chemical characterization and antileishmanial activity of oil extracts from three medicinal plants belonging to genus Artemisia (Asteracea), that grow in central Tunisia. The chemical composition of volatile compounds had been elucidated by gas chromatography-mass spectroscopy analysis. Chemical analysis revealed that essential oils were composed of 34 compounds: α-thujone (29.3%), chamazulene (39.2%) and β-pinene (32%), were the main constituents for the essential oils of Artemesia herba alba, Artemesia absinthium and Artemesia campestris, respectively. The hydrodistilled essential oils from these three species of Artemisia showed significant anti-leishmanial activities against Leishmania major. Oils from A. herba alba, A. absinthium and A. campestris exhibited IC50 values of 1.20 ± 0.043 μg/mL, 1.49 ± 0.05 μg/mL and 2.20 ± 0.11 μg/mL respectively against promastigotes of Leishmania major. Among three oils tested, A. campestris exerted a remarkable antileishmanial activity and it has the lowest cytotoxicity effect compared to amphotericin B. Overall, it was proved that our investigated essential oils possess potential antileishmanial properties and could be used as a promising alternative treatment for leishmaniasis disease in the future.